| FIWGX | GIBLX | FIWGX / GIBLX | |
| Total Expense Ratio | 0.16 | 0.85 | 19% |
| Annual Report Gross Expense Ratio | 0.41 | 0.91 | 45% |
| Fund Existence | 7 years | 11 years | - |
| Gain YTD | 7.381 | 7.348 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 86.7B | 30.1B | 288% |
| Annual Yield % from dividends | 4.26 | 4.71 | 90% |
| Returns for 1 year | 7.44 | 7.50 | 99% |
| Returns for 3 years | 18.53 | 20.39 | 91% |
| Returns for 5 years | -1.17 | -2.05 | 57% |
| Returns for 10 years | N/A | 29.17 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BUXX | 20.30 | 0.01 | +0.02% |
| Strive Enhanced Income Short MaturityETF | |||
| BIB | 74.47 | -1.60 | -2.10% |
| ProShares Ultra Nasdaq Biotechnology | |||
| IAI | 175.04 | -4.25 | -2.37% |
| iShares US Broker-Dealers&Secs Exchs ETF | |||
| CTEX | 34.95 | -2.73 | -7.24% |
| ProShares S&P Kensho Cleantech ETF | |||
| AVGG | 28.12 | -2.77 | -8.95% |
| Leverage Shares 2X Long AVGO Daily ETF | |||